WCM Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-285,665
| Closed | -$5.27M | – | 319 |
|
|
2024
Q3 | $5.27M | Sell |
285,665
-7,236
| -2% | -$134K | 0.01% | 166 |
|
|
2024
Q2 | $6.28M | Sell |
292,901
-4,757
| -2% | -$102K | 0.01% | 156 |
|
|
2024
Q1 | $8.02M | Buy |
297,658
+1,645
| +0.6% | +$44.3K | 0.02% | 148 |
|
|
2023
Q4 | $9.15M | Buy |
296,013
+7,212
| +2% | +$223K | 0.03% | 144 |
|
|
2023
Q3 | $5.89M | Buy |
288,801
+5,867
| +2% | +$120K | 0.02% | 147 |
|
|
2023
Q2 | $5.62M | Buy |
282,934
+29,123
| +11% | +$579K | 0.02% | 151 |
|
|
2023
Q1 | $4.35M | Buy |
253,811
+2,113
| +0.8% | +$36.2K | 0.01% | 159 |
|
|
2022
Q4 | $4.93M | Sell |
251,698
-139,232
| -36% | -$2.72M | 0.02% | 160 |
|
|
2022
Q3 | $5.49M | Buy |
390,930
+20,181
| +5% | +$283K | 0.02% | 147 |
|
|
2022
Q2 | $4.83M | Buy |
370,749
+163,575
| +79% | +$2.13M | 0.02% | 149 |
|
|
2022
Q1 | $3.29M | Buy |
207,174
+14,245
| +7% | +$226K | 0.01% | 155 |
|
|
2021
Q4 | $4.21M | Buy |
192,929
+95,664
| +98% | +$2.09M | 0.01% | 156 |
|
|
2021
Q3 | $2.91M | Buy |
97,265
+464
| +0.5% | +$13.9K | 0.01% | 162 |
|
|
2021
Q2 | $4.29M | Buy |
96,801
+3,811
| +4% | +$169K | 0.01% | 141 |
|
|
2021
Q1 | $4.13M | Sell |
92,990
-2,145
| -2% | -$95.2K | 0.01% | 141 |
|
|
2020
Q4 | $5.22M | Buy |
+95,135
| New | +$5.22M | 0.01% | 143 |
|